iCad Inc.

3.59+0.0400+1.13%Vol 180.34K1Y Perf -76.17%
May 13th, 2022 16:00 DELAYED
BID3.56 ASK3.75
Open3.59 Previous Close3.55
Pre-Market- After-Market-
 - -%  - -
Target Price
17.00 
Analyst Rating
Moderate Buy 1.67
Potential %
373.54 
Finscreener Ranking
★★★+     51.70
Insiders Trans % 3/6/12 mo.
-/-9/-57 
Value Ranking
★★★+     52.88
Insiders Value % 3/6/12 mo.
-/-8/-66 
Growth Ranking
★★★     52.38
Insiders Shares Cnt. % 3/6/12 mo.
-/-13/-54 
Income Ranking
 —    -
Price Range Ratio 52W %
4.23 
Earnings Rating
Strong Sell
Market Cap90.40M 
Earnings Date
11th May 2022
Alpha-0.00 Standard Deviation0.19
Beta1.27 

Today's Price Range

3.523.71

52W Range

2.9119.00

5 Year PE Ratio Range

-8.00-5.40

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
-2.97%
1 Month
-0.28%
3 Months
-31.36%
6 Months
-59.98%
1 Year
-76.17%
3 Years
-38.42%
5 Years
-27.77%
10 Years
52.77%

TickerPriceChg.Chg.%
ICAD3.590.04001.13
AAPL147.114.55003.19
GOOG2 330.3167.09002.96
MSFT261.125.77002.26
XOM88.862.56002.97
WFC42.640.83001.99
JNJ176.85-1.0200-0.57
FB198.627.38003.86
GE75.051.77002.42
JPM119.091.05000.89
Financial StrengthValueIndustryS&P 500US Markets
2.90
3.40
0.01
0.02
-78.70
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
72.10
-33.00
-31.40
-48.20
-38.42
RevenueValueIndustryS&P 500US Markets
24.99M
0.99
7.35
4.23
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.10-0.14-40.00
Q04 2021-0.11-0.17-54.55
Q03 2021-0.09-0.090.00
Q02 2021-0.08-0.11-37.50
Q01 2021-0.11-0.0736.36
Q04 2020-0.08-0.0625.00
Q03 2020-0.12-0.0833.33
Q02 2020-0.16-0.1225.00
Earnings Per EndEstimateRevision %Trend
3/2022 QR-0.10-42.86Negative
6/2022 QR-0.12-140.00Negative
12/2022 FY-0.53-130.44Negative
12/2022 FY-0.23-283.33Negative
Next Report Date-
Estimated EPS Next Report-0.10
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume180.34K
Shares Outstanding25.18K
Shares Float23.18M
Trades Count2.66K
Dollar Volume647.50K
Avg. Volume206.10K
Avg. Weekly Volume193.45K
Avg. Monthly Volume232.94K
Avg. Quarterly Volume191.90K

iCad Inc. (NASDAQ: ICAD) stock closed at 3.59 per share at the end of the most recent trading day (a 1.13% change compared to the prior day closing price) with a volume of 180.34K shares and market capitalization of 90.40M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 138 people. iCad Inc. CEO is Michael Klein.

The one-year performance of iCad Inc. stock is -76.17%, while year-to-date (YTD) performance is -50.14%. ICAD stock has a five-year performance of -27.77%. Its 52-week range is between 2.91 and 19, which gives ICAD stock a 52-week price range ratio of 4.23%

iCad Inc. currently has a PE ratio of -8.20, a price-to-book (PB) ratio of 2.00, a price-to-sale (PS) ratio of 3.63, a price to cashflow ratio of 21.00, a PEG ratio of 2.32, a ROA of -19.10%, a ROC of -25.57% and a ROE of -29.19%. The company’s profit margin is -38.42%, its EBITDA margin is -31.40%, and its revenue ttm is $24.99 Million , which makes it $0.99 revenue per share.

Of the last four earnings reports from iCad Inc., there were 0 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.10 for the next earnings report. iCad Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for iCad Inc. is Moderate Buy (1.67), with a target price of $17, which is +373.54% compared to the current price. The earnings rating for iCad Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

iCad Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

iCad Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 11.08, ATR14 : 0.28, CCI20 : 40.40, Chaikin Money Flow : -0.03, MACD : -0.10, Money Flow Index : 50.59, ROC : -2.71, RSI : 48.51, STOCH (14,3) : 49.28, STOCH RSI : 0.85, UO : 49.54, Williams %R : -50.72), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of iCad Inc. in the last 12-months were: Andrew H. Sassine (Sold 120 000 shares of value $1 009 500 ), Charles Ross Carter (Buy at a value of $49 350), Jonathan Go (Option Excercise at a value of $94 500), Jonathan Go (Sold 8 750 shares of value $95 025 ), Michael Klein (Buy at a value of $99 446), Nathaniel Dalton (Buy at a value of $49 956), Stacey Stevens (Buy at a value of $104 927), Stacey Stevens (Option Excercise at a value of $38 068), Stacey Stevens (Sold 22 735 shares of value $407 810 ), Susan Wood (Buy at a value of $10 965)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (66.67 %)
3 (75.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (33.33 %)
1 (33.33 %)
1 (25.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.67
Moderate Buy
1.67
Strong Buy
1.50

iCad Inc.

icad Inc provides cancer detection, radiation therapy and workflow solutions, primarily computer-aided detection and workflow solutions for breast, prostate and colorectal cancers. Its products include powerlook tomo detection, powerlook density assessment, and vera look. The firm has also developed a technology namely Xoft Axxent electronic brachytherapy system used in the treatment of non-melanoma skin cancer, early-stage breast cancer, and gynecological cancers.

CEO: Michael Klein

Telephone: +1 603 882-5200

Address: 98 Spit Brook Road, Nashua 03062, NH, US

Number of employees: 138

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

59%41%

Bearish Bullish

58%42%

TipRanks News for ICAD

Tue, 01 Mar 2022 06:05 GMT Analysts Top Technology Picks: iCAD (ICAD), PubMatic (PUBM)

- TipRanks. All rights reserved.

News

Stocktwits